Amanote Research

Amanote Research

    RegisterSign In

CNS Cancer Immunity Cycle and Strategies to Target This for Glioblastoma

Oncotarget - United States
doi 10.18632/oncotarget.24896
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

March 20, 2018

Authors
Malaka AmeratungaNiamh ColemanLiam WelshFrank SaranJuanita Lopez
Publisher

Impact Journals, LLC


Related search

Complementing the Cancer-Immunity Cycle

Frontiers in Immunology
AllergyImmunology
2019English

Access to the CNS: Biomarker Strategies for Dopaminergic Treatments

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2018English

RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer

AAPS Journal
Pharmaceutical Science
2016English

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

Biomimetic Strategies for the Glioblastoma Microenvironment

Frontiers in Materials
Materials Science
2017English

Viral Vectors and Delivery Strategies for CNS Gene Therapy

Therapeutic Delivery
Pharmaceutical Science
2010English

Vaccine Strategies for Glioblastoma: Progress and Future Directions

Immunotherapy
OncologyAllergyImmunology
2013English

STING: A Master Regulator in the Cancer-Immunity Cycle

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

Immunity to Cancer.

BMJ
1969English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy